MapLight Therapeutics was assigned a Hold rating ahead of its Phase 2 ZEPHYR readout for ML-007C-MA in schizophrenia expected ...

Novo Nordisk A/S outlook: 2026 guidance warns revenue/profit declines as GLP-1 competition, pricing pressure & patent risks ...

Comorbid ASD in youth with ADHD is linked to greater healthcare utilization and distinct medication treatment patterns.

Telescopes 4 inches or less in diameter are portable, easy to use, and great beginner instruments. Here, I’ll walk through ...

If you're looking for an alternative to store-bought mosquito repellents, these herbs and oils have been proven to be highly ...

However,instead of attacking cancer cells, they are typically co-opted to support tumor growth, metastasis, and therapeutic ...

The report compiles 26 sourced data points on market growth, FDA approvals, and the purity problem dividing regulated ...

Oath Research, a Gilbert, Arizona–based research peptide supplier, today released an analysis of the regulatory and analytical ...

Reports of emotional flattening among some users of semaglutide (Ozempic) have brought new attention to how glucagon-like ...

Pickle juice muscle cramps may be relieved via a nerve reflex, not electrolyte replacement, research shows. The post Does ...

Detailed price information for Artara Therapeutics Inc (TARA-Q) from The Globe and Mail including charting and trades.

Detailed price information for Artara Therapeutics Inc (TARA-Q) from The Globe and Mail including charting and trades.